Centene Enters Agreement to Buy Behavioral Health Stalwart Magellan Health

Centene Corp. on Jan. 5 said it agreed to acquire Magellan Health, one of the largest independently held providers of behavioral health services in the U.S. Magellan is currently contracted to serve 19 payer clients (see the top three below), which enroll about 16.5 million medical lives overall, according to the latest update to AIS’s Directory of Health Plans. Centene owns the fifth-largest behavioral health organization (BHO) in the national payer landscape, Cenpatico, and is also affiliated with Managed Health Network, a BHO inherited from Centene’s 2016 acquisition of Health Net. Centene is also set to acquire Magellan’s wholly owned PBM, Magellan Rx Management. Magellan currently serves 5.5 million pharmacy lives, while Centene’s PBM subsidiary Envolve Pharmacy Solutions has 6.1 million lives as of MMIT’s third-quarter 2020 lives data update.

NOTE: As behavioral contracts may only apply to specific lines of business, medical lives described above do not necessarily represent total lives serviced by BHOs in this graphic.
*Anthem, Inc. completed its acquisition of Beacon Health Options, a BHO serving about 12 million medical lives, in March 2020. Beacon is represented as a separate entity in DHP.

SOURCE: DHP, AIS’s Directory of Health Plans, as of December 2020.

Carina Belles

Carina is a reporter at AIS, specializing in public sector data research, trend analysis and infographics. She holds a Bachelor of Science in Journalism from Ohio University, joining AIS shortly after graduating in 2014.

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured-Image-radar-on-specialty-pharmacy-Another-Immunotherapy-Indication-Will-Be-Withdrawn.jpg
November 18

FDA Grants Interchangeable Status to Humira Biosimilar, but Certain Factors May Hamper Its, Other Adalimumabs’ Uptake

Read More
https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured-Image-radar-on-drug-benefits-OptumRx-Spotlights-Two-Drugs-That-Treat-Rare-Liver-Diseases.jpg
November 18

Oncologists Show Interest in Prescribing New CML STAMP Inhibitor Scemblix

Read More
https://www.mmitnetwork.com/wp-content/uploads/2021/10/WordPress-Featured-Image-RADAR-on-Drug-Benefits-Eli-Lilly-Pounces-on-Flailing-Aduhelm-With-Competing-Drug.jpg
November 18

Eli Lilly Pounces on Flailing Aduhelm With Competing Drug

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today